XML 17 R7.htm IDEA: XBRL DOCUMENT v3.23.2
CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS’ EQUITY - USD ($)
$ in Millions
Total
Redeemable Noncontrolling Interest
Common Stock
Additional Paid-In Capital
Accumulated Other Comprehensive Income (Loss)
Accumulated Deficit
Balance, beginning of period at Dec. 26, 2021   $ 15.2        
Redeemable Noncontrolling Interest            
Net Income (loss)   0.3        
Balance, end of period at Jun. 26, 2022   7.8        
Balance, beginning of period (in shares) at Dec. 26, 2021     124,000,000.0      
Balance, beginning of period at Dec. 26, 2021 $ 945.1   $ 0.0 $ 1,578.9 $ 0.6 $ (634.4)
Increase (Decrease) in Stockholders' Equity            
Stock-based compensation 13.3     13.3    
Issuance of common stock for employee stock purchase plan and stock options (in shares)     200,000      
Issuance of common stock for employee stock purchase plan and stock options 2.9     2.9    
Restricted stock issued and related taxes (in shares)     900,000      
Restricted stock issued and related taxes (11.5)     (11.5)    
Issuance of common stock for acquisitions (in shares)     300,000      
Issuance of common stock for acquisitions 5.0     5.0    
Net Income (loss) (20.6)         (20.6)
Other comprehensive income (loss), net of tax (0.6)       (0.6)  
Changes in noncontrolling interest (in shares)     200,000      
Changes in noncontrolling interest 4.5 (7.7)        
Balance, end of period (in shares) at Jun. 26, 2022     125,600,000      
Balance, end of period at Jun. 26, 2022 938.1   $ 0.0 1,593.1 0.0 (655.0)
Balance, beginning of period at Mar. 27, 2022   15.2        
Redeemable Noncontrolling Interest            
Net Income (loss)   0.3        
Balance, end of period at Jun. 26, 2022   7.8        
Balance, beginning of period (in shares) at Mar. 27, 2022     124,800,000      
Balance, beginning of period at Mar. 27, 2022 932.3   $ 0.0 1,582.0 0.6 (650.3)
Increase (Decrease) in Stockholders' Equity            
Stock-based compensation 6.4     6.4    
Restricted stock issued and related taxes (in shares)     300,000      
Restricted stock issued and related taxes (4.8)     (4.8)    
Issuance of common stock for acquisitions (in shares)     300,000      
Issuance of common stock for acquisitions 5.0     5.0    
Net Income (loss) (4.7)         (4.7)
Other comprehensive income (loss), net of tax (0.6)       (0.6)  
Changes in noncontrolling interest (in shares)     200,000      
Changes in noncontrolling interest 4.5 (7.7)   4.5    
Balance, end of period (in shares) at Jun. 26, 2022     125,600,000      
Balance, end of period at Jun. 26, 2022 $ 938.1   $ 0.0 1,593.1 0.0 (655.0)
Balance, beginning of period at Dec. 25, 2022   11.2        
Redeemable Noncontrolling Interest            
Net Income (loss)   3.5        
Balance, end of period at Jun. 25, 2023   14.7        
Balance, beginning of period (in shares) at Dec. 25, 2022 125,985,306   126,000,000.0      
Balance, beginning of period at Dec. 25, 2022 $ 936.3   $ 0.0 1,608.4 (0.8) (671.3)
Increase (Decrease) in Stockholders' Equity            
Stock-based compensation 12.6     12.6    
Issuance of common stock for employee stock purchase plan and stock options (in shares)     300,000      
Issuance of common stock for employee stock purchase plan and stock options 2.9     2.9    
Restricted stock issued and related taxes (in shares)     500,000      
Restricted stock issued and related taxes (3.4)     (3.4)    
Net Income (loss) (9.7)         (9.7)
Other comprehensive income (loss), net of tax 3.7       3.7  
Changes in noncontrolling interest (in shares)     800,000      
Changes in noncontrolling interest $ 3.2     3.2    
Balance, end of period (in shares) at Jun. 25, 2023 127,641,905   127,600,000      
Balance, end of period at Jun. 25, 2023 $ 945.6   $ 0.0 1,623.7 2.9 (681.0)
Balance, beginning of period at Mar. 26, 2023   12.4        
Redeemable Noncontrolling Interest            
Net Income (loss)   2.3        
Balance, end of period at Jun. 25, 2023   $ 14.7        
Balance, beginning of period (in shares) at Mar. 26, 2023     126,700,000      
Balance, beginning of period at Mar. 26, 2023 931.2   $ 0.0 1,610.0 (0.5) (678.3)
Increase (Decrease) in Stockholders' Equity            
Stock-based compensation 6.0     6.0    
Restricted stock issued and related taxes (in shares)     100,000      
Restricted stock issued and related taxes (0.8)     (0.8)    
Net Income (loss) (2.7)         (2.7)
Other comprehensive income (loss), net of tax 3.4       3.4  
Changes in noncontrolling interest (in shares)     800,000      
Changes in noncontrolling interest $ 8.5     8.5    
Balance, end of period (in shares) at Jun. 25, 2023 127,641,905   127,600,000      
Balance, end of period at Jun. 25, 2023 $ 945.6   $ 0.0 $ 1,623.7 $ 2.9 $ (681.0)